Modern orvostudományi diagnosztikus eljárások és terápiák fejlesztése transzlációs
megközelítésbe...(EFOP-3.6.2-16-2017-00006) Funder: EFOP
(EFOP-3.6.1-16-2016-00022) Funder: EFOP
(GINOP-2.3.2-15-2016-00048)
TÉMATERÜLETI KIVÁLÓSÁGI PROGRAM 2020(2020-4.1.1-TKP2020)
Subjects:
Meta-analysis
Introduction: The lips and the mouth play an indispensable role in vocalization, mastication
and face aesthetics. Various noxious factors may alter and destruct the original structure,
and appearance of the lips and the anatomical area surrounding the mouth. The application
of hyaluronic acid (HA) may serve as a safe method for lip regeneration. Although
a number of studies exist for HA effectiveness and safety, its beneficial effect is
not well-established. Aim: The present meta-analysis and systematic review was performed
to investigate the effectiveness of HA on lip augmentation. We also investigated the
types and nature of adverse effects (AEs) of HA application. Methods: We reported
our meta-analysis in accordance with the PRISMA Statement. PROSPERO protocol registration:
CRD42018102899. We performed the systematic literature search in CENTRAL, Embase,
and MEDLINE. Randomized controlled trials, cohort studies, case series and case reports
were included. The untransformed proportion (random-effects, DerSimonian-Laird method)
of responder rate to HA injection was calculated. For treatment related AEs descriptive
statistics were used. Results: The systematic literature search yielded 32 eligible
records for descriptive statistics and 10 records for quantitative synthesis. The
results indicated that the overall estimate of responders (percentage of subjects
with increased lip fullness by one point or higher) was 91% (ES = 0.91, 95% CI:0.85-0.96)
2 months after injection. The rate of responders was 74% (ES = 0.74, 95% CI:0.66-0.82)
and 46% (ES = 0.46, 95% CI:0.28-0.65) after 6 and 12 months, respectively. We included
1,496 participants for estimating the event rates of AEs. The most frequent treatment-related
AEs were tenderness (88.8%), injection site swelling (74.3%) and bruising (39.5%).
Rare AEs included foreign body granulomas (0.6%), herpes labialis (0.6%) and angioedema
(0.3%). Conclusion: Our meta-analysis revealed that lip augmentation with injectable
HA is an efficient method for increasing lip fullness for at least up to 6 months
after augmentation. Moreover, we found that most AEs of HA treatment were mild or
moderate, but a small number of serious adverse effects were also found. In conclusion,
further well-designed RCTs are still needed to make the presently available evidence
stronger.